Longeveron (LGVN) Misses Q4 EPS by 1c

Longeveron (NASDAQ: LGVN) reported Q4 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $121 thousand versus the consensus estimate of $400 thousand.

For earnings history and earnings-related data on Longeveron (LGVN) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Intuit holds investor day, reaffirms fiscal 2027 guidance
• Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)